CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 49 filers reported holding CHAMPIONS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,000 | -1.0% | 31,238 | 0.0% | 0.00% | – |
| Q2 2023 | $196,000 | +55.6% | 31,238 | 0.0% | 0.00% | – |
| Q1 2023 | $126,000 | -10.6% | 31,238 | 0.0% | 0.00% | – |
| Q4 2022 | $141,000 | -29.1% | 31,238 | +18.0% | 0.00% | -100.0% |
| Q3 2022 | $199,000 | -7.0% | 26,467 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $214,000 | -0.5% | 26,467 | 0.0% | 0.00% | – |
| Q1 2022 | $215,000 | +1.4% | 26,467 | 0.0% | 0.00% | – |
| Q4 2021 | $212,000 | -21.5% | 26,467 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $270,000 | +35.0% | 26,467 | +36.2% | 0.00% | 0.0% |
| Q2 2021 | $200,000 | -9.1% | 19,427 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $220,000 | +22.9% | 19,427 | +17.0% | 0.00% | 0.0% |
| Q4 2020 | $179,000 | +16.2% | 16,600 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $154,000 | -3.1% | 16,600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $159,000 | +29.3% | 16,600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $123,000 | -10.9% | 16,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $138,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Battery Partners IX, LLC | 1,953,549 | $10,451,000 | 3.89% |
| NEA Management Company, LLC | 1,562,500 | $8,359,000 | 0.55% |
| Perceptive Advisors | 745,194 | $3,986,000 | 0.16% |
| Par Capital Management | 833,333 | $4,458,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 169,397 | $893,000 | 0.04% |
| Alexandria Capital, LLC | 1,188 | $6,000 | 0.00% |
| MORGAN STANLEY | 2,690 | $14,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 47 | $0 | 0.00% |
| UBS Group AG | 483 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,089 | $11,000 | 0.00% |